6'-Guanidinonaltrindole
| 6'-Guanidinonaltrindole | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
6'-Guanidinonaltrindole (6'-GNTI) is a chemical compound that acts as a selective kappa-opioid receptor agonist. It is structurally related to naltrindole, a delta-opioid receptor antagonist, but has been modified to selectively target the kappa-opioid receptor.
Pharmacology[edit]
6'-Guanidinonaltrindole exhibits high affinity and selectivity for the kappa-opioid receptor over other opioid receptors, such as the mu-opioid receptor and delta-opioid receptor. This selectivity makes it a valuable tool in the study of kappa-opioid receptor functions and the development of new therapeutic agents targeting this receptor.
Research Applications[edit]
Due to its selectivity, 6'-Guanidinonaltrindole is used in pharmacological research to investigate the role of kappa-opioid receptors in various physiological and pathological processes. It has been studied in the context of pain management, addiction, and mood disorders.
See also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
